Literature DB >> 18096094

Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort.

Raul Zamora-Ros1, Cristina Andres-Lacueva, Rosa M Lamuela-Raventós, Toni Berenguer, Paula Jakszyn, Carmen Martínez, María J Sánchez, Carmen Navarro, María D Chirlaque, María-José Tormo, Jose R Quirós, Pilar Amiano, Miren Dorronsoro, Nerea Larrañaga, Aurelio Barricarte, Eva Ardanaz, Carlos A González.   

Abstract

Resveratrol has been shown to have beneficial effects on diseases related to oxidant and/or inflammatory processes and extends the lifespan of simple organisms including rodents. The objective of the present study was to estimate the dietary intake of resveratrol and piceid (R&P) present in foods, and to identify the principal dietary sources of these compounds in the Spanish adult population. For this purpose, a food composition database (FCDB) of R&P in Spanish foods was compiled. The study included 40,685 subjects aged 35-64 years from northern and southern regions of Spain who were included in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort. Usual food intake was assessed by personal interviews using a computerised version of a validated diet history method. An FCDB with 160 items was compiled. The estimated median and mean of R&P intake were 100 and 933 microg/d respectively. Approximately, 32% of the population did not consume R&P. The most abundant of the four stilbenes studied was trans-piceid (53.6%), followed by trans-resveratrol (20.9%), cis-piceid (19.3%) and cis-resveratrol (6.2%). The most important source of R&P was wines (98.4%) and grape and grape juices (1.6%), whereas peanuts, pistachios and berries contributed to less than 0.01%. For this reason the pattern of intake of R&P was similar to the wine pattern. This is the first time that R&P intake has been estimated in a Mediterranean country.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18096094     DOI: 10.1017/S0007114507882997

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  27 in total

Review 1.  Influence of berry polyphenols on receptor signaling and cell-death pathways: implications for breast cancer prevention.

Authors:  Harini S Aiyer; Anni M Warri; Denzel R Woode; Leena Hilakivi-Clarke; Robert Clarke
Journal:  J Agric Food Chem       Date:  2012-02-22       Impact factor: 5.279

2.  Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet.

Authors:  M T Macarulla; G Alberdi; S Gómez; I Tueros; C Bald; V M Rodríguez; J A Martínez; M P Portillo
Journal:  J Physiol Biochem       Date:  2009-12       Impact factor: 4.158

3.  Association of habitual dietary resveratrol exposure with the development of frailty in older age: the Invecchiare in Chianti study.

Authors:  Montserrat Rabassa; Raul Zamora-Ros; Mireia Urpi-Sarda; Stefania Bandinelli; Luigi Ferrucci; Cristina Andres-Lacueva; Antonio Cherubini
Journal:  Am J Clin Nutr       Date:  2015-10-21       Impact factor: 7.045

Review 4.  Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Authors:  Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

5.  Resveratrol ameliorates high-glucose-induced hyperpermeability mediated by caveolae via VEGF/KDR pathway.

Authors:  Chong Tian; Rui Zhang; Xiaolei Ye; Changhui Zhang; Xin Jin; Yukio Yamori; Liping Hao; Xiufa Sun; Chenjiang Ying
Journal:  Genes Nutr       Date:  2012-09-16       Impact factor: 5.523

Review 6.  Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy?

Authors:  Sabine Weiskirchen; Ralf Weiskirchen
Journal:  Adv Nutr       Date:  2016-07-15       Impact factor: 8.701

7.  Comparative toxicokinetics of Trans-resveratrol and its major metabolites in Harlan Sprague Dawley rats and B6C3F1/N mice following oral and intravenous administration.

Authors:  Esra Mutlu; Seth T Gibbs; Natalie South; Jessica Pierfelice; Brian Burback; Dori Germolec; Suramya Waidyanatha
Journal:  Toxicol Appl Pharmacol       Date:  2020-03-20       Impact factor: 4.219

Review 8.  The Potential of Resveratrol to Act as a Caloric Restriction Mimetic Appears to Be Limited: Insights from Studies in Mice.

Authors:  Kathrin Pallauf; Ilka Günther; Gianna Kühn; Dawn Chin; Sonia de Pascual-Teresa; Gerald Rimbach
Journal:  Adv Nutr       Date:  2021-06-01       Impact factor: 8.701

9.  Dietary polyphenol intake in Europe: the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

Authors:  Raul Zamora-Ros; Viktoria Knaze; Joseph A Rothwell; Bertrand Hémon; Aurelie Moskal; Kim Overvad; Anne Tjønneland; Cecilie Kyrø; Guy Fagherazzi; Marie-Christine Boutron-Ruault; Marina Touillaud; Verena Katzke; Tilman Kühn; Heiner Boeing; Jana Förster; Antonia Trichopoulou; Elissavet Valanou; Eleni Peppa; Domenico Palli; Claudia Agnoli; Fulvio Ricceri; Rosario Tumino; Maria Santucci de Magistris; Petra H M Peeters; H Bas Bueno-de-Mesquita; Dagrun Engeset; Guri Skeie; Anette Hjartåker; Virginia Menéndez; Antonio Agudo; Esther Molina-Montes; José María Huerta; Aurelio Barricarte; Pilar Amiano; Emily Sonestedt; Lena Maria Nilsson; Rikard Landberg; Timothy J Key; Kay-Thee Khaw; Nicholas J Wareham; Yunxia Lu; Nadia Slimani; Isabelle Romieu; Elio Riboli; Augustin Scalbert
Journal:  Eur J Nutr       Date:  2015-06-17       Impact factor: 5.614

10.  Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease.

Authors:  João Tomé-Carneiro; Manuel Gonzálvez; Mar Larrosa; María J Yáñez-Gascón; Francisco J García-Almagro; José A Ruiz-Ros; Francisco A Tomás-Barberán; María T García-Conesa; Juan Carlos Espín
Journal:  Cardiovasc Drugs Ther       Date:  2013-02       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.